ProCE Banner Activity

CE / CME

Strategies for Individualizing Management of Inflammatory Bowel Disease: Episode 2

Podcast Episodes

Optimal care for patients with inflammatory bowel disease (IBD) includes timely and accurate diagnosis, early initiation of evidence-based and individualized therapies, and long-term prevention and management of extraintestinal manifestations and adverse events (AEs). In this second of 4 episodes adapted from a presentation at the PCE Gastroenterology Bootcamp, IBD specialists Anita Afzali, MD, Nana Bernasko, DNP, and Richard Davis, PA-C review therapeutic options, potential treatment AEs, and guideline recommendations. Through the discussion of a clinical case, you’ll hear about applying patient-specific principles in IBD management.

To access all episodes in this series, click here.

Registered Nurses: 0.25 Nursing contact hours, includes 0.25 hour of pharmacology credit Physician Assistants: maximum of 0.25 hours of AAPA Category 1 CME credits

Released: May 16, 2022

Expiration: May 15, 2023

Begin Activity

Share

Faculty

Anita Afzali

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair
Department of Internal Medicine
Associate Chief Medical Officer
University of Cincinnati, UC Health System
Cincinnati, Ohio

Nana Bernasko

Nana Bernasko, DNP, CRNP, WHNP-BC

Assistant Professor
Division of Gastroenterology and Hepatology
Department of Medicine
Penn State University Medical Center
Hershey, Pennsylvania

Richard H. Davis

Richard H. Davis, PA-C

Senior Physician Assistant
Division of Gastroenterology, Hepatology, and Nutrition
University of Florida College of Medicine
Gainesville, Florida

Acknowledgement

This activity is supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.

This activity is supported by educational grants from Amgen; and Ferring Pharmaceuticals, Inc.

Provided by

ProCE Banner

Target Audience

NPs and PAs practicing in gastroenterology

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Determine the appropriateness of incorporating a top-down approach into the management of patients with IBD

  • Integrate clinical evidence, recent real-world data, current guidance, and patient preferences into individualized treatment plans for patients with IBD

  • Devise a plan for long-term management of IBD that includes treatment of extraintestinal manifestations and treatment AEs

Disclosure

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Afzali: consultant/advisor/speaker: AbbVie, DiaSorin, Eli Lilly, Gilead, Janssen, Pfizer, Takeda, TLL Pharmaceuticals.

Dr Bernasko: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Pfizer.

Mr Davis has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Bernasko as noted above.

CME Info

Participants wishing to earn CE/CME credit must:

  1. Listen to the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.

The estimated time to complete this activity is 0.25 hours.

Release date: May 16, 2022
Expiration date: May 15, 2023

Format

Podcast

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Accreditation

PCE

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP Course Advisor: Nana Bernasko, DNP, CRNP, WHNP-BC, Penn State University Medical Center, Hershey, Pennsylvania

Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until May 15, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Richard H. Davis, PA-C, University of Florida College of Medicine, Gainesville, Florida

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Additional Information

Program Medium

This program has been made available online.